Events and Networking

Expand Your Network at One of Biocom’s 150+ Annual Events

Partner Day with Boehringer Ingelheim

When

Thu Sep 21 21:15:00 GMT 2017 - Fri Sep 22 02:00:00 GMT 2017

Where

10996 Torreyana Road
San Diego, CA 92121

Register

Championing Innovation in San Diego: Boehringer Ingelheim Partnering Day - September 21st 2017
Boehringer Ingelheim knows what it takes to be innovative and entrepreneurial. From the small factory in 1885 to today’s multi-billion-dollar global pharmaceutical organization, we know how important it is to nurture and develop young science and technology businesses. Our track record of bringing breakthrough medicines to patients starts with new ideas and new science. And collaborations with external partners play an essential role in helping us deliver an innovation-led portfolio. We look forward to meeting you at our partnering day so we can learn from each other to develop the next generation of medicines.

Meet our Research and Partnering Team
Our research and partnering leadership teams will be available throughout the day for one-on-one meetings and at our networking reception in the evening:

  • Learn more about our research and partnering interests
  • Hear how our corporate Venture Fund drives innovation through its strategic investment in early-stage science and technology
  • Join our panel discussion and Q&A: ‘Collaborative Science and Partnering with BI’ where representatives from Boehringer Ingelheim, academia and equity investors, together with Boehringer Ingelheim partners, will talk about our approach to research and partnering.

For more details, please see below for our full agenda.

User-added imageUser-added imageUser-added image

Dr. Paola Casarosa, Corporate Vice President, Business Development and Licensing
Dr. Clive Wood, Senior Vice President, Human Pharma Discovery Research
Dr. Martin Heidecker, Director, Investment Manager of the Boehringer Ingelheim Venture Fund  

Our Partnering Interests  
We work closely with all stakeholders in the innovation ecosystem – from pharma to biotechs to academia to starts ups – to help achieve our innovation ambition of delivering meaningful breakthroughs that improve patients’ lives. With industry-leading levels of investment, including 1.5 billion euro designated for external innovation,* we are increasing our emphasis on collaborations and expanding our global network of innovation partners.

*Five-year investment designated 2016-2020

For more information about our specific partnering interests please download our flyers. 

User-added imageUser-added imageUser-added imageUser-added imageUser-added imageUser-added image User-added image


How to Apply
If you are interested in discussing potential opportunities for partnering with the Boehringer Ingelheim team in a one-to-one meeting, please send a one-page non-confidential executive summary to Oscar Rodarte at orodarte@biocom.org by September 5, 2017. 

Biocom Hosts Boehringer Ingelheim’s Partnering Day in San Diego
One of Biocom’s most valuable roles is as facilitator for our member companies, which takes many forms. Biocom Partner Days is one of those programs. This program brings buyers and sellers together to discuss partnerships, licensing opportunities and/or M&A deals. Companies are selected for one-on-one meetings through an application process, where the selection committee will identify companies that best fit the partnering strategy. Accepted companies are scheduled in meetings/presentations with the company executives. We invite you to apply and are now accepting company applications - see below for details. Also, please join us for presentations, a panel discussion and networking reception on September 21st from 2:00 PM - 7:00 PM. Space is limited and registration is required.



Transparency about our Engagements with Healthcare Providers

Boehringer Ingelheim Pharmaceuticals, Inc. has adopted the PhRMA Code on Interactions with Healthcare Professionals.  Pursuant to the Code, inclusion of the healthcare professional’s spouse or guest is not permitted at this event.  We appreciate your understanding and support of our commitment to following the highest ethical standards related to interactions with healthcare professionals.

Boehringer Ingelheim Pharmaceuticals, Inc. is committed to complying with all applicable laws and industry guidance related to the provision of gifts and hospitality.  We abide by all state and federal disclosure laws and if required by law, we will attribute and report any items of value (e.g. food, beverage, etc.) provided to relevant individuals at this event.  If you are a Colorado State Employee or a Healthcare Professional licensed in Vermont, due to state law restrictions, please refrain from accepting the items being offered at this event.  If you are a Louisiana State Employee or Healthcare Professional licensed in Minnesota, please contact the event coordinator prior to accepting any items.  If any other law or institutional policy limits your ability to accept these items, you are responsible for complying with any such requirement.
 

Price of Admission

Biocom Non-Member

Today's Price: 0.0

Important Dates

Amount

Registration Before

Registration Before

Registration Before

Refund after Thu Sep 14 00:00:00 GMT 2017

0.0

Refund after

Refund after

Biocom Member

Today's Price: 0.0

Important Dates

Amount

Registration Before

Registration Before

Registration Before

Refund after Thu Sep 14 00:00:00 GMT 2017

0.0

Refund after

Refund after

  • Agenda

    Agenda: Boehringer Ingelheim Partnering Day 

    8:00am – 1:00pm
       One-One Partnering Meetings

    1:00pm – 2:00pm   Break

    2:15pm – 3:15pm   Company Presentations

    Dr. Clive Wood, Senior Vice President, Human Pharma Discovery Research
    Dr. Paola Casarosa, Corporate Vice President, Business Development and Licensing
    Dr. Martin Heidecker, Director, Investment Manager of the Boehringer Ingelheim Venture Fund 

    3:15pm – 4:15pm   Panel Discussion: Collaborative Science and Partnering with BI

    4:30pm – 7:00pm   Networking Reception*


    *Space is limited and registration is required.


    In Partnership with: 

    User-added image

     

    a0d2A00000DTniWQAT
    Go
  • Apply - 1:1 Meeting

    How to Apply
    If you are interested in discussing potential opportunities for partnering with the Boehringer Ingelheim team in a one-to-one meeting, please send a one-page non-confidential executive summary to Oscar Rodarte at orodarte@biocom.org by September 5th.

    Our Partnering Interests 

    We work closely with all stakeholders in the innovation ecosystem – from pharma to biotechs to academia to starts ups – to help achieve our innovation ambition of delivering meaningful breakthroughs that improve patients’ lives. With industry-leading levels of investment, including 1.5 billion euro designated for external innovation,* we are increasing our emphasis on collaborations and expanding our global network of innovation partners.

    For more information about our specific partnering interests please download our flyers. 

    CardioMetabolic diseases
    CNS diseases
    Immunology
    Oncology
    Respiratory diseases
    Technologies
    Research Beyond Borders

    *Five-year investment designated 2016-2020


    In Partnership with:

    User-added image
     

    a0d2A00000DTnl6QAD
    Go

Register